The market size of C-Arms in the North American region is forecasted to be worth USD 2.17 billion by 2028 from USD 1.8 billion in 2023 and showcasing a CAGR of 3.78% between 2023 to 2028.
The growing prevalence of chronic diseases such as CVDs, diabetes and respiratory disease primarily drives the growth of the C-arms market in North America. Factors such as lifestyle changes, rising obesity rates, and excessive alcohol consumption contribute significantly to the incidence of chronic diseases in North America, especially cardiovascular diseases. CVDs hold the unfortunate distinction of being the leading cause of death in the United States. Shockingly, approximately one person dies every 34 seconds in the country due to heart disease, accounting for one in every five deaths as reported in 2020. In the field of cardiac examination, healthcare providers rely on advanced equipment such as C-Arm devices. C-Arm is a specialized X-ray machine widely utilized in outpatient surgeries, orthopedic procedures, and pain management. Its functionality in fluoroscopy procedures enables the capture of detailed internal images of the body. The flexibility of the c-shaped connecting element allows for seamless horizontal, vertical, and multi-angled movement of the C-Arm device, enhancing its efficacy and usability for medical professionals.
The growing number of surgical procedures being performed each year in North American countries further contributes to the North American C-arms market growth. Healthcare providers rely on mini-C-Arms specifically designed for complex surgeries, enabling them to obtain high-quality images in the surgical department. These images play a crucial role in the diagnosis and treatment of patients. Additionally, the mini-C-Arm allows for dynamic imaging, facilitating manipulations and injections during surgical procedures. Given the rise in surgical errors, healthcare providers are adopting C-Arm devices to enhance visualization of the affected areas, ensuring a clearer picture and increasing the success rate of surgeries.
Technological advancements further propel the growth rate of the North American C-arms market. Manufacturers are focused on developing devices with cutting-edge technology to enhance flexibility and improve treatment outcomes for various chronic diseases. The rising emphasis on research and development by the key market participants to bring new and improved C-Arm devices, the growing investments from governmental and non-governmental organizations and favorable reimbursement policies further boost the growth of the North American C-arms market growth.
High costs associated with the procurement and maintenance of C-arms are one of the key factors hampering the regional market growth. The scarcity of skilled professionals and stringent regulatory approval process for C-arms further hinder regional market growth.
This research report on the North American C-arms market has been segmented and sub-segmented into the following categories:
By Device type:
The North American C-arms market held the leading share of the global market in 2022 and is estimated to continue its domination throughout the forecast period.
The U.S. C-Arms market led the North American market in 2022 and is predicted to grow at a promising CAGR during the forecast period. The presence of healthcare infrastructure, the growing patient population of cardiovascular disease and the pressure for C-arm imaging equipment are predicted to augment the market growth in the U.S. The growing frequency of diagnostic examination and the increasing aging population further boost the U.S. market growth.
The Canadian C-arms market is expected to showcase notable growth in the North American region during the forecast period. Increasing familiarity with minimally invasive surgeries and utilizing these C-arms is extended to assist spinal surgery, cardiac, urology neurovascular applications, and vascular surgery. 46.0% of adults in the U.S. suffer from hypertension every year, according to the American Heart Association (AHA).
KEY MARKET PLAYERS:
Companies playing a dominant role in the North America C-Arms Market profiled in this report are GE Healthcare Inc., Varian Medical Systems Inc., Philips Healthcare, Siemens AG, Toshiba Corp., Hologic corp., Omega Medical Imaging Inc., BMI Biomedical International, Hitachi Ltd., DMS Health Technologies, ATON GmbH, Medonica Co Ltd., Gemss Co Ltd., and Shimadzu Corp. The market is highly consolidated due to the high prices of equipment, and a considerable amount of capital is required for the entry of a new company into the market. It has led to formidable competition among prominent market players.
The North America C-Arms market is predicted to grow at a CAGR of 3.78% from 2023 to 2028.
The growth of the C-Arms market in North America is driven by factors such as the increasing number of surgical procedures, advancements in C-Arm technology, rising demand for minimally invasive surgeries, and the need for real-time imaging during complex procedures.
The key challenges in the North America C-Arms market include the high cost of C-Arm devices, availability of skilled professionals to operate and interpret the imaging, infrastructure requirements, and the regulatory approval process for new devices.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com